On the recordJuly 19, 2011
Patients, industry and the FDA can benefit from a more predictive regulatory framework.
Source
congress.govEditor's note · Context
Gingrey advocates for regulatory reform to improve predictability in FDA processes for medical devices.
Share & report
More from Phil Gingrey
Jul 18, 2012
I fully support H. Con. Res. 132. This, of course, would ensure the printing and production of Hispanic Americans in Congress.
Feb 13, 2013
I think it is really unconstitutional to say that Congress doesn't have the ability to mitigate as we do under the good advice that you give us.
Mar 12, 2013
We're afraid to grow. The lack of information is creating fear, and it's not good for the economy.
Mar 14, 2013
This is a bipartisan bill. I would like to again urge my colleagues to sign on to it.
Other voices in this conversation
